Reviews on
Prostate Cancer


Volume 7 Number 9
September 2019


Home > Disciplines > Publications > Reviews on Prostate Cancer > Volume 7, Year 2019 > Number 9, September



CONTENTS


DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



DIAGNOSIS


Elschot M, Selnæs KM, Langørgen S, Johansen H, Bertilsson H, Tandstad T, Bathen TF.
Prostate-Specific Membrane Antigen PET/Magnetic Resonance Imaging for the Planning of Salvage Radiotherapy in Patients with Prostate Cancer with Biochemical Recurrence After Radical Prostatectomy.
PET Clin. 2019 Oct;14(4):487-498. doi: 10.1016/j.cpet.2019.06.003. Epub 2019 Aug 2.
Source . Similar articles




Goel S, Shoag JE, Gross MD, Al Hussein Al Awamlh B, Robinson B, Khani F, Baltich Nelson B, Margolis DJ, Hu JC.
Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis.
Eur Urol Oncol. 2019 Sep 4. pii: S2588-9311(19)30121-X. doi: 10.1016/j.euo.2019.08.001. [Epub ahead of print]
Source . Similar articles




Ghafoor S, Burger IA, Vargas AH.
Multimodality Imaging of Prostate Cancer.
J Nucl Med. 2019 Oct;60(10):1350-1358. doi: 10.2967/jnumed.119.228320. Epub 2019 Sep 3.
Source . Similar articles




Stelcer E, Konkol M, Głȩboka A, Suchorska WM.
Liquid Biopsy in Oligometastatic Prostate Cancer-A Biologist's Point of View.
Front Oncol. 2019 Aug 14;9:775. doi: 10.3389/fonc.2019.00775. eCollection 2019.
Source . Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION


Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A.
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.
Eur Urol. 2019 Sep 4. pii: S0302-2838(19)30619-0. doi: 10.1016/j.eururo.2019.08.005. [Epub ahead of print]
Source . Similar articles




Fitzmaurice C, Abate D, Abbasi N, et al.
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.
JAMA Oncol. 2019 Sep 27. doi: 10.1001/jamaoncol.2019.2996. [Epub ahead of print]
Source . Similar articles




Najafi A, Chaechi Nosrati MR, Ghasemi E, Navi Z, Yousefi A, Majidiani H, Ghaneialvar H, Sayehmiri K, De la Luz Galvan-Ramirez M, Fakhar M.
Is there association between Trichomonas vaginalis infection and prostate cancer risk?: A systematic review and meta-analysis.
Microb Pathog. 2019 Sep 17;137:103752. doi: 10.1016/j.micpath.2019.103752. [Epub ahead of print]
Source . Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY


Tsing T, Beretov J, Ni J, Bai X, Bucci J, Graham P, Li Y.
Cancer stem cells in prostate cancer radioresistance.
Cancer Lett. 2019 Nov 28;465:94-104. doi: 10.1016/j.canlet.2019.08.020. Epub 2019 Sep 4.
Source . Similar articles



OVERALL MANAGEMENT


Cimadamore A, Scarpelli M, Raspollini MR, Doria A, Galosi AB, Massari F, Di Nunno V, Cheng L, Lopez-Beltran A, Montironi R.
Prostate cancer pathology: What has changed in the last 5 years.
Urologia. 2019 Sep 23:391560319876821. doi: 10.1177/0391560319876821. [Epub ahead of print]
Source . Similar articles



PROGNOSIS


Westerberg M, Franck Lissbrant I, Damber JE, Robinson D, Garmo H, Stattin P.
Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study.
Acta Oncol. 2019 Sep 17:1-6. doi: 10.1080/0284186X.2019.1662084. [Epub ahead of print]
Source . Similar articles



TREATMENT


Cattrini C, Castro E, Lozano R, Zanardi E, Rubagotti A, Boccardo F, Olmos D.
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer.
Cancers (Basel). 2019 Sep 12;11(9). pii: E1355. doi: 10.3390/cancers11091355.
Source . Similar articles




Gilligan T, et al., PDQ Adult Treatment Editorial Board.
Prostate Cancer Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Sep 20.
Source . Similar articles




Langbein T, Weber WA, Eiber M.
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.
J Nucl Med. 2019 Sep;60(Suppl 2):13S-19S. doi: 10.2967/jnumed.118.220566.
Source . Similar articles




Paller CJ, Eisenberger MA.
Progress in the Systemic Management of Advanced Prostate Cancer: The Hormone-Sensitive Paradigm.
J Clin Oncol. 2019 Sep 4:JCO1901863. doi: 10.1200/JCO.19.01863. [Epub ahead of print]
Source . Similar articles




Reimers MA, Slane KE, Pachynski RK.
Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: Past and Future Strategies for Optimization.
Curr Urol Rep. 2019 Sep 3;20(10):64. doi: 10.1007/s11934-019-0931-3.
Source . Similar articles




Rice MA, Malhotra SV, Stoyanova T.
Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer.
Front Oncol. 2019 Aug 28;9:801. doi: 10.3389/fonc.2019.00801. eCollection 2019.
Source . Similar articles




Roy S, Hyndman ME, Danielson B, Fairey A, Lee-Ying R, Cheung WY, Afzal AR, Xu Y, Abedin T, Quon HC.
Active treatment in low-risk prostate cancer: a population-based study.
Curr Oncol. 2019 Aug;26(4):e535-e540. doi: 10.3747/co.26.4953. Epub 2019 Aug 1.
Source . Similar articles




VanderWeele DJ, Antonarakis ES, Carducci MA, Dreicer R, Fizazi K, Gillessen S, Higano CS, Morgans AK, Petrylak DP, Sweeney CJ, Hussain M.
Metastatic Hormone-Sensitive Prostate Cancer: Clinical Decision Making in a Rapidly Evolving Landscape of Life-Prolonging Therapy.
J Clin Oncol. 2019 Sep 10:JCO1901595. doi: 10.1200/JCO.19.01595. [Epub ahead of print]
Source . Similar articles




Wang L, Yang H, Li B.
Photodynamic therapy for prostate cancer: a systematic review and meta-analysis.
Prostate Int. 2019 Sep;7(3):83-90. doi: 10.1016/j.prnil.2018.12.002. Epub 2018 Dec 27.
Source . Similar articles



bottom